The following is the status of pending multidistrict litigation (MDL) and recalls among the major global manufacturers of orthopedic medical devices:
2158 IN RE: Zimmer Durom Hip Cup Products Liability Litigation / District of New Jersey (Susan D. Wigenton)
In 2016, Zimmer Inc. reached a binding settlement agreement to resolve claims of patients who underwent revision surgery for a Durom Acetabular Component hip (Durom Cup). Only plaintiffs who had “qualified revision surgery” less than nine years after the date of implantation would be eligible for either a base award of $175,000 subject to enhancement or reduction, or a fixed award of $25,000. Claimants who rejected the award were required to request mediation to be schedule by February 28, 2017. Zimmer will not make any payment unless 67 percent of eligible claimants accept the award offer by September 29, 2017.
2197 IN RE: DePuy Orthopaedics, Inc., ASR Hip #Implant Products Liability Litigation / Northern District of Ohio (Jeffrey J. Helmick)
Still pending notwithstanding settlement whereby DePuy agreed to pay $2.5 billion to settle approximately 8,000 lawsuits by United States patients who had hip revision surgery as of August 31, 2013. In January 2017, the New Jersey state court judge overseeing the docket issued its 40th case management order, extending the discovery end date in a number of cases to September 30, 2017.
2244 IN RE: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation / Northern District of Texas (James Edgar Kinkeade)
On December 1, 2016, in the third set of bellwether trials, a Texas federal jury awarded $40 million in compensatory damages and more than $1 billion in punitive damages to six plaintiffs who alleged that DePuy Orthopaedics Inc.’s Pinnacle metal-on-metal hip implants were defectively designed and that the company failed to warn doctors and consumers about complications possible from the device, which included pain and subsequent revision surgeries. Johnson & Johnson prevailed in the first bellwether trial in 2014, and the second bellwether trial in March 2016 yielded a $500 million jury award to five plaintiffs. The court ordered that $140 million would be applied to collective compensatory damages with $360 million being awarded in punitive damages. A fourth bellwether trial, which will involve 10 patients, is scheduled for September 2017.
2272 IN RE: Zimmer NexGen Knee Implant Products Liability Litigation / Northern District of Illinois (Rebecca R. Pallmeyer)
At least 5,900 product liability lawsuits have been consolidated. In late January 2017, Zimmer won its third bellwether trial. In the first bellwether trial in November 2015, the jury found for Zimmer given that the plaintiff failed to prove defective design and failure to warn claims. Zimmer also won its second bellwether trial in late 2016 when the judge found that the plaintiff failed to prove that a design defect caused the knee implant to fail.
2329 IN RE: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation / Northern District of Georgia (William S. Duffey)
In November 2016, Wright Medical Group announced a $240 million settlement on behalf of its wholly-owned subsidiary, Wright Medical Technology, which ended five years of litigation brought by 1,300 claimants. Under the terms of the settlement, Wright will pay $170,000 to each claimant who were implanted with its Conserve Cup device, and $120,000 to each claimant who received either a Dynasty or Lineage replacement hip. Wright also established a fund to reimburse patients who suffered “extraordinary injury” resulting from the failure of their hip implants. The settlement applied to patients with lawsuits pending in the multidistrict litigation as well as those included in proceeding in California Superior Court in Los Angeles.
2391 IN RE: Biomet M2a Magnum Hip Implant Products Liability Litigation / Northern District of Indiana (Robert L. Miller)
A settlement program between was announced in early 2014 in which certain patients implanted with Biomet’s defective M2a Magnum hip implant system were to receive up to $200,000. Recently, Judge Miller released an order disclosing that 93 lawsuits were settled in October 2016. Despite this settlement, depositions are ongoing and the admissibility of expert testimony and reports will be litigated through August 2017, with bellwether trials most likely taking place in late 2017 or early 2018.
2441 IN RE: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation / District of Minnesota (Donovan W. Frank)
In November 2014, Stryker settled approximately 3,000 Rejuvenate Hip Stem and ABG II Modular Hip Stem lawsuits in New Jersey’s Bergen County Superior Court, the 17th Judicial Circuit Court of Florida, the 15th Judicial Circuit Court of Florida, and the MDL. Pursuant to the settlement, Stryker agreed to pay hip implant patients a base award of $300,000 for each revised hip, with additional compensation for patients who had complications during revision surgery to remove the hip implant. On December 19, 2016, Judge Frank ordered that individuals who had initial implant surgery and revision surgery by December 19, 2016 were eligible to participate in the settlement. Further, hip implant patients who were eligible for the settlement in November 2014 but did not enroll were deemed still eligible to participate in the settlement.
Stryker Orthopaedics LFit V40 Femoral Head
The United States Judicial Panel on Multidistrict Litigation (JPML) announced it would hear oral arguments on March 30th to consider consolidating present and future lawsuits against Stryker arising from the LFit V40 femoral head defect into an MDL in the United States District Court for the District of Massachusetts.
Smith & Nephew Birmingham Hip Resurfacing (BHR) System and R3 Acetabular System
Plaintiffs injured by the premature failure of the Smith & Nephew Birmingham Hip Resurfacing (BHR) System and R3 Acetabular System have filed a petition with the Judicial Panel on Multidistrict Litigation (JPML) on February 1, 2017 to consolidate all pending federal BHR and R3 cases in Maryland federal court.
Zimmer Biomet Comprehensive Reverse Shoulder System Humeral Tray Model 115340
Last week, the United States Food & Drug Administration (FDA) released information on a Class 1 recall of Zimmer Biomet‘s Comprehensive Reverse Shoulder System. Zimmer Biomet’s Comprehensive Reverse Shoulder system is a shoulder replacement device designed to be surgically implanted to restore arm movement in patients with rotator cuff tears who have developed artropathy and have failed shoulder joint replacements.
Modular SMF and Modular Redapt Femoral Hip Systems Recall
In November 2016, Smith & Nephew recalled its Modular SMF and Modular Redapt hip implants “due to a higher than anticipated complaint and adverse event trend” with the modular necks used in the devices. Smith & Nephew also recalled the corresponding hip stem components.
Tandem Bipolar Hip System Recall
On August 29, 2016, Smith & Nephew recalled certain batches of its Tandem Bipolar Hip System in the United States due to a retainer groove that is out of specifications that can cause the artificial hip joint to disassmeble, usually within the first few weeks of surgery. This necessitates painful revision surgery to remove and replace the defective artificial joint and treat injuries caused by the implant failure. Smith & Nephew stated that the defect will be discovered before the device is implanted in most cases as surgeons will notice that the device did not assemble properly. All unused units have been recalled.